Funded Research 2012

You are here:

Funded Research

2011-2012 Funded Research

RESEARCH GRANTS: Total Awarded: $1,015,000
Investigator	Institution	Research Project
Radhika P. Atit, PhD Assistant Professor, Department of Dermatology	Case Western Reserve University	Forced Activation of Wnt Signaling in Dermal Fibroblasts: A Genetic Model for Scleroderma
Howard Chang, MD, PhD Associate Professor, Department of Dermatology	Howard Hughes Medical Institute and Program in Epithelial Biology, Stanford University School of Medicine	Regulation of Positional Identity in Scleroderma Skin
Lorinda Chung, MD, MS Assistant Professor of Medicine, Division of Immunology and Rheumatology Recipient of Actelion Center of Excellence Award	Stanford University School of Medicine	Stanford Scleroderma Center of Excellence
Hal Dietz, MD Victor A. McKusick Professor of Genetics and Medicine	Johns Hopkins University School of Medicine; Howard Hughes Medical Institute	Interrogation of the Pathogenesis of Stiff Skin Syndrome: A Congenital Form of Scleroderma
Laurie Glimcher, MD Irene Heinz Given Professor of Immunology and Professor of Medicine Antonios Aliprantis, MD, PhD Assistant Professor, Department of Immunology and Infectious Disease Recipient of Actelion Research Award	Harvard School of Public Health and Harvard Medical School	The Function of the IL4 Receptor and the Chemokine CCL2 in Both Mouse and "Humanized" Mouse Models of Scleroderma
Monique Hinchcliff, MD Associate Professor	Northwestern University Feinberg School of Medicine	The Use of DNA Microarray as a Biomarker for Scleroderma: the Mycophenolate Mofetil Response Signature in Skin
Colin Jamora, PhD Assistant Professor	University of California San Diego	Using the Snail Transgenic Mouse to Elucidate Signaling Pathways Mediating Scleroderma Fibrogenesis
Vibha Lama, MD, MS Assistant Professor, Department of Internal Medicine	University of Michigan, Ann Arbor	Cellular and Biochemical Modulation of Inflammation and Fibrosis in Systemic Sclerosis
Glenn Rosen, MD Associate Professor	Stanford University School of Medicine	Dual mTOR Signaling in Scleroderma Lung Disease
Andrew Tager, MD Assistant Professor of Medicine	Massachusetts General Hospital and Harvard Medical School	Role of the LPA-LPA₁ Pathway in Scleroderma Fibrogenesis
John Varga, MD Professor of Medicine	Northwestern University School of Medicine	PPAR-gamma: A Novel Target in Scleroderma Fibrosis
Michael Whitfield, PhD Assistant Professor of Genetics	Dartmouth Medical School	A Gene Expression Map of Scleroderma
Fredrick Wigley, MD Professor of Medicine, Associate Director of the Division of Rheumatology, Director of the Johns Hopkins Scleroderma Center	Johns Hopkins University School of Medicine	The Johns Hopkins Scleroderma Center

in this section...

donate now

Make an online contribution
to help find a cure for
scleroderma. It’s fast, secure and simple.

quick links

moving forward video

"Moving Forward" is a five minute video sharing the struggles presented by scleroderma.

Ways to Give

There are many ways that you can support the work of the Scleroderma Research Foundation. We are grateful for your commitment to helping the SRF fund research that will result in improved therapies and, ultimately, a cure.

» Click here for details

Make a Donation 1-800-441-CURE (2873)

The Scleroderma Research Foundation is a 501(c)3 nonprofit organization whose mission is to fund and facilitate the most promising medical research aimed at improved therapies and, ultimately, a cure for scleroderma. Information provided by the SRF should not be considered medical advice, nor is it intended to replace consultation with a qualified physician. The SRF does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Scleroderma varies substantially from one patient to another, and treatment must be tailored by a physician for each individual case.